Riskpilot← Back to searchSign inGet full accessSANNAN LEGESENTER AS
ASActiveOrg 915486258Steinkjersannan 5, 7713 SteinkjerGeneral medical practice activities · NACE 8621Est. 20159 employees
Revenue 2024
NOK 8,5M
+36% vs 2023
EBITDA margin
-2.4%
-203% vs 2023
Equity ratio
-17.6%
Financial strength
Net profit 2024
NOK -687K
-1448% vs 2023
| Revenue | NOK 8,5M | +36% |
| EBITDA | NOK -208K | -203% |
| Net profit | NOK -687K | -1448% |
| Total assets | NOK 4,8M | +36% |
| Equity | NOK -836K | -460% |
| Employees | 9 | — |
Legal name
SANNAN LEGESENTER AS
Org number
915486258
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
5. juni 2015
Share capital
NOK 30 000
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drive legesenter i steinkjer kommune med alt som naturlig faller inn under dette, samt å eie og delta i andre selskaper.
Address
Steinkjersannan 5, 7713 Steinkjer
Phone
+4773604260
Email
post@sannanlegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 677 | 4 628 | 5 041 | 6 263 | 8 534 |
| Staff expenses | −2 127 | −2 334 | −2 394 | −2 534 | −3 305 |
| EBITDA | 253 | 12 | 109 | 202 | −208 |
| Depreciation & amort. | −210 | −264 | −137 | −110 | −280 |
| EBIT | 43 | −252 | −28 | 92 | −489 |
| Net financials | −2 | −2 | −11 | −41 | −198 |
| Profit before tax | 41 | −255 | −38 | 51 | −687 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 41 | −255 | −38 | 51 | −687 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 906 | 705 | 547 | 3 501 | 4 759 |
| Equity | 93 | −162 | −200 | −149 | −836 |
| Long-term debt | 0 | 0 | 0 | 2 479 | 2 079 |
| Short-term debt | 813 | 867 | 747 | 1 171 | 3 515 |
| Total debt | 813 | 867 | 747 | 3 650 | 5 595 |
EBITDA margin
-2.4%
This company
15.8%
Market median
-115% vs market
20202024
Equity ratio
-17.6%
This company
38.2%
Market median
-146% vs market
20202024
Return on equity
-68674800.0%
This company
18.4%
Market median
-373232709% vs market
20202024
Net profit margin
-8.0%
This company
8.1%
Market median
-199% vs market
20202024
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20202024
Debt / equity
6.69×
This company
0.62×
Market median
-979% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DZ Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Spero Invest As
SANNAN LEGESENTER AS Board members of SANNAN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dragan Zerajic | Chief Executive Officer | 0 companies |
| Jan Oddvar Setten | Chairman | 0 companies |
| Ingrid Korssjøen | Board of Directors | 0 companies |